These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16279808

  • 21. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
    Mayilmurugan R, Visvaganesan K, Suresh E, Palaniandavar M.
    Inorg Chem; 2009 Sep 21; 48(18):8771-83. PubMed ID: 19694480
    [Abstract] [Full Text] [Related]

  • 22. Novel iron(III) complexes of sterically hindered 4N ligands: regioselectivity in biomimetic extradiol cleavage of catechols.
    Mayilmurugan R, Stoeckli-Evans H, Palaniandavar M.
    Inorg Chem; 2008 Aug 04; 47(15):6645-58. PubMed ID: 18597419
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S, de Lussanet QG, van Genderen MH, Meijer EW, Beets-Tan RG, Griffioen AW, van Engelshoven JM, Backes WH.
    NMR Biomed; 2006 Feb 04; 19(1):133-41. PubMed ID: 16450331
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and characterization of glucosyl-curcuminoids as Fe3+ suppliers in the treatment of iron deficiency.
    Ferrari E, Arezzini B, Ferrali M, Lazzari S, Pignedoli F, Spagnolo F, Saladini M.
    Biometals; 2009 Oct 04; 22(5):701-10. PubMed ID: 19205899
    [Abstract] [Full Text] [Related]

  • 25. Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.
    Bales BC, Grimmond B, Johnson BF, Luttrell MT, Meyer DE, Polyanskaya T, Rishel MJ, Roberts J.
    Contrast Media Mol Imaging; 2019 Oct 04; 2019():8356931. PubMed ID: 31969797
    [Abstract] [Full Text] [Related]

  • 26. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K, Kikuchi K, Terai T, Komatsu T, Nagano T.
    Chemistry; 2008 Oct 04; 14(3):987-95. PubMed ID: 17992679
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and characterization of new beta-diketo derivatives with iron chelating ability.
    Benassi R, Ferrari E, Grandi R, Lazzari S, Saladini M.
    J Inorg Biochem; 2007 Feb 04; 101(2):203-13. PubMed ID: 17097145
    [Abstract] [Full Text] [Related]

  • 28. A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions.
    Livramento JB, Sour A, Borel A, Merbach AE, Tóth E.
    Chemistry; 2006 Jan 23; 12(4):989-1003. PubMed ID: 16311990
    [Abstract] [Full Text] [Related]

  • 29. A class of water-soluble Fe(III) coordination complexes as T1-weighted MRI contrast agents.
    Wang R, An L, He J, Li M, Jiao J, Yang S.
    J Mater Chem B; 2021 Feb 25; 9(7):1787-1791. PubMed ID: 33595044
    [Abstract] [Full Text] [Related]

  • 30. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ, Datta A, Jocher CJ, Raymond KN.
    Angew Chem Int Ed Engl; 2008 Feb 25; 47(45):8568-80. PubMed ID: 18825758
    [Abstract] [Full Text] [Related]

  • 31. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 25; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 32. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S, Torres S, Martins AF, Martins JA, André JP, Helm L, Prata MI, Santos AC, Geraldes CF.
    Dalton Trans; 2009 Jun 28; (24):4656-70. PubMed ID: 19513474
    [Abstract] [Full Text] [Related]

  • 33. Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.
    Zhou T, Neubert H, Liu DY, Liu ZD, Ma YM, Kong XL, Luo W, Mark S, Hider RC.
    J Med Chem; 2006 Jul 13; 49(14):4171-82. PubMed ID: 16821777
    [Abstract] [Full Text] [Related]

  • 34. Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.
    d'Hardemare Adu M, Torelli S, Serratrice G, Pierre JL.
    Biometals; 2006 Aug 13; 19(4):349-66. PubMed ID: 16841245
    [Abstract] [Full Text] [Related]

  • 35. DTPA-bisamide-based MR sensor agents for peroxidase imaging.
    Querol M, Chen JW, Weissleder R, Bogdanov A.
    Org Lett; 2005 Apr 28; 7(9):1719-22. PubMed ID: 15844889
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, structure, spectra and reactivity of iron(III) complexes of facially coordinating and sterically hindering 3N ligands as models for catechol dioxygenases.
    Sundaravel K, Dhanalakshmi T, Suresh E, Palaniandavar M.
    Dalton Trans; 2008 Dec 28; (48):7012-25. PubMed ID: 19050788
    [Abstract] [Full Text] [Related]

  • 37. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
    Miguel OB, Gossuin Y, Morales MP, Gillis P, Muller RN, Veintemillas-Verdaguer S.
    Magn Reson Imaging; 2007 Dec 28; 25(10):1437-41. PubMed ID: 17566686
    [Abstract] [Full Text] [Related]

  • 38. Reactivity of molecular dioxygen towards a series of isostructural dichloroiron(III) complexes with tripodal tetraamine ligands: general access to mu-oxodiiron(III) complexes and effect of alpha-fluorination on the reaction kinetics.
    Thallaj NK, Rotthaus O, Benhamou L, Humbert N, Elhabiri M, Lachkar M, Welter R, Albrecht-Gary AM, Mandon D.
    Chemistry; 2008 Dec 28; 14(22):6742-53. PubMed ID: 18561351
    [Abstract] [Full Text] [Related]

  • 39. Rigid Fe(III) Chelate with Phosphonate Pendants: A Stable and Effective Extracellular MRI Contrast Agent.
    He L, Wang H, Zeng Z, Zhong L, Tang Q, Yu J, Tian J, Liu T, Zhu J.
    J Med Chem; 2024 Jun 13; 67(11):8630-8641. PubMed ID: 38747630
    [Abstract] [Full Text] [Related]

  • 40. Versatility in the binding of 2-pyrazinecarboxylate with iron. Synthesis, structure and magnetic properties of iron(II) and iron(III) complexes.
    Tanase S, Marqués Gallego P, Bouwman E, Long GJ, Rebbouh L, Grandjean F, de Gelder R, Mutikainen I, Turpeinen U, Reedijk J.
    Dalton Trans; 2006 Apr 07; (13):1675-84. PubMed ID: 16547543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.